Glidepath
Payments companies reported to CMS as associated with Glidepath. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Glidepath, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Glidepath
These are the largest totals companies reported as associated with Glidepath. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Namazy | San Diego, CA | Nephrology (Internal Medicine) | $165.74 |
| Naveed Haq | Detroit, MI | Nephrology (Internal Medicine) | $148.58 |
| Mohammad Rashid | Toledo, OH | Hematology & Oncology | $148.58 |
| Brandon Repko | Las Vegas, NV | Vascular & Interventional Radiology | $148.58 |
| Rafael Santini Dominguez | Ponce, PR | Vascular Surgery | $141.64 |
| Jorge Weber Guzman | Memphis, TN | Vascular Surgery | $117.87 |
| Gabriel Pereira Torrellas | Ponce, PR | Vascular Surgery | $117.87 |
| Delfin Bernal | Bayamon, PR | Body Imaging | $94.60 |
| Manuel Cruz | Manati, PR | Nephrology (Internal Medicine) | $94.60 |
| Michelle Cofan Hernandez | Toa Baja, PR | Nephrology (Internal Medicine) | $94.60 |
Prescribed Glidepath?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.